HROW

Harrow Health, Inc.

Healthcare›Drug Manufacturers - Specialty & Generic|NASDAQ Global Market|US

Price

$35.31

Market Cap

$1.31B

Beta

0.10

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+36.41%

EPS Growth (YoY)+66.57%

Revenue CAGR 3Y+45.39%

P/E Ratio0.0

PEG Ratio—

FCF Yield+3.27%

Debt / Equity4.80

Interest Coverage1.3x

No credit card required

Already have an account? Sign in to view the full analysis for HROW.